Lynda Polgreen
Pediatric Endocrinology · Orange, CANPI 1679617930
Payments from drug & device makers
Across 640 payments — averaging $7004.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$2.5M
- AbbVie$1.3M
- Pfizer$466K
- Takeda Pharmaceuticals U.S.A., Inc.$110K
- Amgen$52K
- Sanofi-aventis U.S. LLC$27K
- plus $40K from 9 others
Across 4 payments — averaging $1077.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 512 | $2,486,726 |
| AbbVie | 3 | $1,302,478 |
| Pfizer | 66 | $465,506 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $109,717 |
| Amgen | 1 | $52,313 |
| Sanofi-aventis U.S. LLC | 7 | $26,626 |
| Sanofi | 12 | $22,861 |
| Therachon Holding GmbH | 3 | $16,153 |
| Eli Lilly | 1 | $550 |
| Corcept Therapeutics | 5 | $82 |
| Lilly USA, LLC | 3 | $43 |
| Jazz Pharmaceuticals Inc. | 1 | $36 |
| AstraZeneca | 1 | $31 |
| Medtronic | 1 | $29 |
| Eton Pharmaceuticals, Inc. | 1 | $25 |
How this compares
$4,483,174 in reported general payments places this provider in the 95th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Orange
- Mark DanielsOrange$298K
- Timothy FlanneryOrange$206K
- Himala KashmiriOrange$113K
- Nikita ForghaniOrange$62K
- Lien TrinhOrange$11K
- Daina DreimaneOrange$6K
- Gnanagurdasan PrakasamSacramento$3.8M
- Michael GottschalkSan Diego$2.4M
- Lily ChaoLos Angeles$2.2M
- Kevin KaisermanWest Covina$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.